BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 26377103)

  • 21. Diagnosis and treatment of idiopathic intracranial hypertension.
    Raoof N; Hoffmann J
    Cephalalgia; 2021 Apr; 41(4):472-478. PubMed ID: 33631966
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Octreotide: The IIH therapy beyond weight loss, carbonic anhydrase inhibitors, lumbar punctures and surgical/interventional treatments.
    House PM; Stodieck SR
    Clin Neurol Neurosurg; 2016 Nov; 150():181-184. PubMed ID: 27690252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Shunt freedom and clinical resolution of idiopathic intracranial hypertension after bariatric surgery in the pediatric population: report of 3 cases.
    Hoang KB; Hooten KG; Muh CR
    J Neurosurg Pediatr; 2017 Dec; 20(6):511-516. PubMed ID: 28960170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of idiopathic intracranial hypertension via stereotactic placement of biventriculoperitoneal shunts.
    Karsy M; Abou-Al-Shaar H; Bowers CA; Schmidt RH
    J Neurosurg; 2018 Feb; 130(1):136-144. PubMed ID: 29393752
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Spectrum of benign intracranial hypertension in children and adolescents.
    Amacher AL; Spence JD
    Childs Nerv Syst; 1985; 1(2):81-6. PubMed ID: 4005888
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on Idiopathic Intracranial Hypertension Management.
    Souza MNP; Costa BAL; Santos FRDR; Fortini I
    Arq Neuropsiquiatr; 2022 May; 80(5 Suppl 1):227-231. PubMed ID: 35976300
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fulminant idiopathic intracranial hypertension and venous stasis retinopathy resulting in severe bilateral visual impairment.
    Voldman A; Durbin B; Nguyen J; Ellis B; Leys M
    Eur J Ophthalmol; 2017 Mar; 27(2):e25-e27. PubMed ID: 28009405
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features of late-onset pseudotumor cerebri fulfilling the modified dandy criteria.
    Bandyopadhyay S; Jacobson DM
    J Neuroophthalmol; 2002 Mar; 22(1):9-11. PubMed ID: 11937898
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intracranial hypertension.
    Kabat AG
    Optom Clin; 1996; 5(3-4):153-79. PubMed ID: 8972512
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for failed transverse sinus stenting in pseudotumor cerebri patients.
    Goodwin CR; Elder BD; Ward A; Orkoulas-Razis D; Kosztowski TA; Hoffberger J; Moghekar A; Radvany M; Rigamonti D
    Clin Neurol Neurosurg; 2014 Dec; 127():75-8. PubMed ID: 25459247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Shunting on Visual Outcomes and Headache in Patients with Idiopathic Intracranial Hypertension.
    Daou BJ; Sweid A; Weinberg JH; Starke RM; Sergott RC; Doermann AS; Hauge J; Zanaty M; Chalouhi N; Gooch R; Herial N; Zarzour H; Jabbour P; Rosenwasser RH; Tjoumakaris S
    World Neurosurg; 2020 Oct; 142():e73-e80. PubMed ID: 32474095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Visual outcomes and headache following interventions for idiopathic intracranial hypertension.
    Lai LT; Danesh-Meyer HV; Kaye AH
    J Clin Neurosci; 2014 Oct; 21(10):1670-8. PubMed ID: 24974193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical variants of pseudotumor cerebri syndrome].
    Koepp M; Lempert T; Poewe W
    Nervenarzt; 1995 Jun; 66(6):397-402. PubMed ID: 7637826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of Intracranial Pressure Monitoring Frequently Refutes Diagnosis of Idiopathic Intracranial Hypertension.
    Xu DS; Hlubek RJ; Mulholland CB; Knievel KL; Smith KA; Nakaji P
    World Neurosurg; 2017 Aug; 104():167-170. PubMed ID: 28435117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
    Wall M; Thurtell MJ;
    Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Outcomes of endoscopic optic nerve decompression in patients with idiopathic intracranial hypertension.
    Tarrats L; Hernández G; Busquets JM; Portela JC; Serrano LA; González-Sepúlveda L; Sánchez-Pérez JR
    Int Forum Allergy Rhinol; 2017 Jun; 7(6):615-623. PubMed ID: 28383199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH).
    Kalyvas A; Neromyliotis E; Koutsarnakis C; Komaitis S; Drosos E; Skandalakis GP; Pantazi M; Gobin YP; Stranjalis G; Patsalides A
    Neurosurg Rev; 2021 Apr; 44(2):773-792. PubMed ID: 32335853
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Headache from increased cerebrospinal fluid pressure].
    Göbel H; Göbel C; Heinze A
    Schmerz; 2012 Jun; 26(3):331-40; quiz 341. PubMed ID: 22760466
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Asymptomatic idiopathic intracranial hypertension in young children.
    Weig SG
    J Child Neurol; 2002 Mar; 17(3):239-41. PubMed ID: 12026246
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Idiopathic intracranial hypertension.
    Dhungana S; Sharrack B; Woodroofe N
    Acta Neurol Scand; 2010 Feb; 121(2):71-82. PubMed ID: 19930211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.